2
190
7
2
1
Cat. No. | Product Name | ||
---|---|---|---|
CL0092 | GSK-3 inhibitor kit | ||
L1100 | 蛋白酶抑制剂库 | 344 compounds | |
A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
L7800 | 高溶解性片段库 | 2731 compounds | |
Structurally diverse, medicinally active, and unique chemistry (strong IP potential); | |||
L5610 | Golden骨架库 | 10000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source; | |||
CL0057 | PI3K inhibitor kit | ||
CL0094 | FLT3 inhibitor kit | ||
L3980 | DNA损伤/修复库Plus | 667 compounds | |
Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
L6010 | 天然产物库 | 3720 compounds | |
A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L8800 | 药物片段库 | 1158 compounds | |
1158 drug fragments,a must-have tool for FBDD; | |||
L2180 | 抗肿瘤库Plus | 1468 compounds | |
Well-chosen 1468 anti-tumor compounds with unique structures; | |||
L1300 | PI3K/Akt/mTOR 化合物库 | 425 compounds | |
A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
L1610 | FDA 上市激酶抑制剂库 | 280 compounds | |
Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research. | |||
DO1200 | 药物靶点库 | ||
L1600 | 激酶抑制剂库 | 2230 compounds | |
A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
L2400 | 内分泌激素分子库 | 813 compounds | |
A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L7600 | 趋化因子抑制剂库 | 59 compounds | |
A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
L8700 | 铁死亡化合物库 | 800 compounds | |
A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study; | |||
L5900 | 血脑屏障通透化合物库 | 516 compounds | |
A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
DO2200 | 共价抑制剂库CD | ||
L1710 | 抗COVID-19化合物库 | 1160 compounds | |
A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | |||
L8500 | HIF-1化合物库 | 1352 compounds | |
A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies; | |||
L5500 | 毒性化合物库 | 277 compounds | |
A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
L9410 | 共价抑制剂库 | 941 compounds | |
A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc. | |||
DC1170 | 特权片段注释化合物库-Oxidoreductases | ||
CL0091 | MEK inhibitor kit | ||
L3200 | 自噬库 | 1248 compounds | |
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L1000 | 上市药物库 | 2863 compounds | |
A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L4900 | 心血管毒性化合物库 | 127 compounds | |
A unique collection of 127 cardiotoxicity inducing compounds for toxicological study; | |||
L9830 | 抗帕金森病化合物库 | 908 compounds | |
A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
DC1150 | 特权片段注释化合物库-GPCR Family B | ||
L2700 | 肾上腺素能受体化合物库 | 219 compounds | |
A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | |||
L2160 | 抗癌活性化合物库 | 2439 compounds | |
A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L7200 | 钙通道分子库 | 143 compounds | |
A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening; | |||
L2195 | 抗前列腺癌化合物库 | 2096 compounds | |
2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
DC1100 | 特权片段注释化合物库-GPCR Frizzled family | ||
L1200 | 表观遗传库 | 960 compounds | |
Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L9411 | 半胱氨酸共价化合物库 | 72 compounds | |
The cysteine covalent library contains 72 compounds. | |||
L2110 | 抗癌上市药物库 | 1806 compounds | |
A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2200 | 酪氨酸激酶分子库 | 746 compounds | |
A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
L2130 | 抗癌细胞代谢库 | 1280 compounds | |
A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
L6700 | 抗癌天然产物库 | 1800 compounds | |
A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L8710 | 铜死亡化合物库 | 411 compounds | |
TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
L6620 | 抗寄生虫天然产物库 | 233 compounds | |
A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
L7820 | 高溶解性微型片段化合物库 | 1082 compounds | |
The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. | |||
L3700 | JAK-STAT 化合物库 | 256 compounds | |
A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
L4660 | 神经疾病库Plus | 1246 compounds | |
Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
DP9200 | DGK抑制剂库 | ||
L7000 | 活性脂质化合物库 | 385 compounds | |
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | |||
L1310 | 细胞骨架化合物库 | 590 compounds | |
A unique collection of 590 cytoskeleton-related compounds, can be used for HTS and HCS; | |||
L6020 | 天然产物单体化合物库 | ||
L8600 | 泛素化化合物库 | 214 compounds | |
A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening; | |||
LF1000 | 预制多样性库 | ||
L7810 | 高溶解性多官能团片段化合物库 | 1159 compounds | |
Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules. | |||
DC1030 | 特权片段注释化合物库-Epigenetics | ||
CL0141 | Notch pathway inhibitor kit | ||
L1120 | AMPK靶向分子库 | 64 compounds | |
64 well-chosen unique AMPK-targeted small molecules; | |||
L5300 | 线粒体靶向库 | 447 compounds | |
A unique collection of 447 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
CL0129 | Aurora Kinase inhibitor kit | ||
L9230 | ReFRAME 相关化合物库 | 3274 compounds | |
A unique collection of 3274 compounds for high-throughput screening and high-content screening, | |||
L1380 | 转录因子库 | 704 compounds | |
Well-chosen 704 compounds with unique structures targeting transcription factor; | |||
L3900 | DNA 损伤和修复分子库 | 937 compounds | |
A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1110 | 微管靶向化合物库 | 80 compounds | |
A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS; | |||
L9850 | 口服活性化合物库 | 2484 compounds | |
A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | |||
DC1200 | 特权片段注释化合物库-Isomerases | ||
DC1040 | 特权片段注释化合物库-Transferases | ||
L5400 | 抗心血管疾病化合物库 | 1428 compounds | |
A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
DC1140 | 特权片段注释化合物库-Ligand-gated | ||
L2196 | 抗卵巢癌化合物库 | 1888 compounds | |
L7900 | 成骨分子库 | 320 compounds | |
A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | |||
L6150 | 天然产物共价化合物库 | 596 compounds | |
Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
DC1190 | 特权片段注释化合物库-Sigma Opioid receptors | ||
L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening; | |||
CL0066 | P450 inhibitor kit | ||
L9810 | 抗纤维化化合物库 | 1180 compounds | |
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
L6610 | 抗感染天然产物库 | 1070 compounds | |
A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
L2194 | 抗结直肠癌化合物库 | 1565 compounds | |
1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
L9400 | PPI抑制剂库 | 260 compounds | |
A unique collection of 260 PPI-related compounds for drug screening; | |||
CL0149 | β-/γ-secretase inhibitor kit | ||
L4000 | 经典已知活性库 | 12862 compounds | |
TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research. | |||
L3500 | 组蛋白修饰化合物库 | 362 compounds | |
A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L9610 | 环肽库 | 58 compounds | |
58 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
DC1180 | 特权片段注释化合物库-Lyases | ||
L9210 | 儿童药物库 | 1015 compounds | |
A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening. | |||
L9420 | 外泌体相关化合物库 | 54 compounds | |
54 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
CL0106 | HIF/HIF-PH inhibitor/activator kit | ||
NY1000 | 天然产物衍生物库 | 4000 compounds | |
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
L1800 | 抗感染化合物库 | 2977 compounds | |
A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
L6400 | 海洋天然产物库 | 94 compounds | |
A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L2151 | 化疗药物库 | 51 compounds | |
51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
L7110 | 抗高血压化合物库 | 719 compounds | |
719 hypertension-related small molecules for high-throughput and high-content screening. | |||
L5700 | 精选片段库 | 246 compounds | |
A unique collection of 246 fragment-like small molecules for FBDD; | |||
L2120 | 抗癌临床化合物库 | 2359 compounds | |
A unique collection of 2359 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L7300 | 钾通道分子库 | 160 compounds | |
A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening; | |||
CL0137 | E1/E2/E3 Enzyme inhibitor kit | ||
L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library | |||
L2000 | 抑制剂库 | 7618 compounds | |
A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L7500 | 凝血与抗凝化合物库 | 154 compounds | |
A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L4150 | 新颖已知活性精选库 | 990 compounds | |
It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 990 compounds without compro | |||
CL0124 | AMPAR antagonist/activator kit | ||
CL0119 | Histone Demethylase inhibitor kit | ||
VM1400 | 多样性核心库Part2 | ||
L6500 | 微生物天然产物库 | 254 compounds | |
254种微生物来源的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L8000 | 干细胞分化化合物库 | 1213 compounds | |
A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
CL0135 | ROCK inhibitor kit | ||
DC1050 | 特权片段注释化合物库-Voltage-gated | ||
L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | |||
L6160 | Ro5类药天然产物库 | 2743 compounds | |
A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
CL0089 | c-Met/HGFR inhibitor kit | ||
DC1010 | 特权片段注释化合物库-GPCR Family A | ||
CL0117 | DPP4 inhibitor kit | ||
L6120 | 黄酮类天然产物库 | 477 compounds | |
A unique collection of 477 flavonoids can be used for high throughput and high content screening; | |||
DC1160 | 特权片段注释化合物库-Toll-like and Il-1 receptors | ||
CL0075 | c-Kit inhibitor kit | ||
L6130 | 萜类天然产物库 | 349 compounds | |
A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening; | |||
L2800 | 5-羟色胺分子库 | 275 compounds | |
A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
CL0067 | Sodium Channel inhibitor kit | ||
CL0114 | ERK inhibitor kit | ||
L8300 | 染色质修饰分子库 | 256 compounds | |
A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
L6030 | 天然产物衍生物虚筛化合物库 | ||
L7850 | 高溶解性3D结构多样性片段化合物库 | 1081 compounds | |
The library of highly soluble 3D structural diversity fragments contains 1081 compounds. | |||
DC1060 | 特权片段注释化合物库-Kinases | ||
CL0118 | p38 inhibitor kit | ||
CL0132 | DHFR inhibitor kit | ||
L9600 | 多肽分子库 | 533 compounds | |
533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
CL0080 | TGFβ signaling pathway inhibitor/activator kit | ||
CL0139 | ROS inhibitor kit | ||
L5600 | Mini骨架库 | 5033 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5033 compounds representing 5033 scaffolds; | |||
CL0070 | GABA Receptor inhibitor kit | ||
L6600 | 胃肠炎天然产物库 | 223 compounds | |
A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
DP9100 | CB1-2化合物库 | ||
DC1220 | 特权片段注释化合物库-Aminoacyltransferases | ||
L2610 | 神经递质受体化合物库 | 1513 compounds | |
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening; | |||
L2600 | 神经信号分子库 | 2011 compounds | |
A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
DC1000 | 特权片段注释化合物库 | ||
L2540 | 肠道微生物代谢化合物库 | 352 compounds | |
A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS; | |||
CL0143 | PKA/cAMP inhibitor/activator kit | ||
CL0126 | Androgen Receptor antagonist kit | ||
CL0144 | Endothelin Receptor antagonist kit | ||
DC1110 | 特权片段注释化合物库-Proteases | ||
CL0085 | HSP inhibitor kit | ||
L2520 | 糖代谢化合物库 | 708 compounds | |
708 glycometabolism-related comounds, can be used for HTS and HCT; | |||
L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
CL0046 | 5-HT Receptor antagonist/agonist kit | ||
L4400 | 抗生素库 | 708 compounds | |
A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | |||
DC1210 | 特权片段注释化合物库-Phosphatases | ||
CL0103 | mGluR agonist/antagonist/modulator kit | ||
L9500 | 表型筛选靶点鉴定库 | 1832 compounds | |
A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening; | |||
CL0084 | FGFR inhibitor kit | ||
L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
DC1130 | 特权片段注释化合物库-Phosphodiesterases | ||
L8720 | 细胞焦亡化合物库 | 1077 compounds | |
1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
L8200 | 抗衰老化合物库 | 3324 compounds | |
A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6300 | 药食同源库 | 1088 compounds | |
A unique collection of 1088 compounds from food as medicine for high throughput and high content screening; | |||
DC1090 | 特权片段注释化合物库-Ligases | ||
L4520 | 抗菌活性库 | 921 compounds | |
A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
L9000 | 细胞凋亡化合物库 | 1796 compounds | |
A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
DC1230 | 特权片段注释化合物库-Beta amyloid A4 protein | ||
L2500 | 人内源代谢化合物库 | 1400 compounds | |
A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | |||
L1510 | 核受体化合物库 | 420 compounds | |
A unique collection of 420 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
L5100 | 含氟化合物库 | 583 compounds | |
A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
L6140 | 糖类及苷类化合物库 | 364 compounds | |
A unique collection of 364 saccharides and glycosides compounds can be used for HTS and HCS; | |||
L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 240 compounds | |
A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
CL0109 | Ras inhibitor kit | ||
L2170 | 肿瘤免疫治疗小分子化合物库 | 454 compounds | |
A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L4800 | 血管生成库 | 1370 compounds | |
A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
DC1020 | 特权片段注释化合物库-Spiro Library | ||
L2190 | 抗肺癌化合物库 | 1735 compounds | |
A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; | |||
L7100 | 抗肥胖化合物库 | 1359 compounds | |
A unique collection of 1359 anti-obesity compounds for high throughput and high content screening; | |||
DF4500 | 多样性核心库Part1 | ||
CL0147 | c-FMS inhibitor kit | ||
L5800 | 药物代谢杂质库 | 200 compounds | |
A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | |||
CL0140 | BTK inhibitor kit | ||
L9860 | 抗抑郁症化合物库 | 1181 compounds | |
1181 compounds associated with depression that can be used for high-throughput and high-content screening | |||
L1400 | MAPK 抑制剂库 | 367 compounds | |
A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases; | |||
L3800 | NF-κB 通路分子库 | 560 compounds | |
A unique collection of 560 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
L3600 | 细胞因子抑制剂库 | 613 compounds | |
A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
CL0123 | AMPK inhibitor/activator kit | ||
CL0146 | JNK inhibitor kit | ||
CL0145 | Casein Kinase inhibitor kit | ||
L2140 | 癌细胞分化化合物库 | 413 compounds | |
A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
CL0133 | CXCR inhibitor kit | ||
L9700 | 内质网应激化合物库 | 193 compounds | |
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
L8400 | 血液病分子库 | 524 compounds | |
A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
L6210 | 藏药化合物库 | 754 compounds | |
A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
L4510 | 抗寄生虫库 | 336 compounds | |
336 well-chosen unique anti-parasitic small molecules; | |||
L2191 | 抗乳腺癌化合物库 | 1965 compounds | |
A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | |||
L2150 | 抗癌药物库 | 2900 compounds | |
A unique collection of 2900 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L1580 | GPCR库Plus | 338 compounds | |
Well-chosen 338 GPCR targeting compounds with unique structures; | |||
L4710 | 非甾体类抗炎化合物库 | 530 compounds | |
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. |
Cat. No. | Product Name | Form | Specificity Of Inhibition |
---|---|---|---|
C0004 |
Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)
磷酸酶抑制剂 Cocktail III |
2 Tube Solution (100×) | Each Tube has different specificity of inhibition |
C0005 |
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8) |
Solution in bottle | |
C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
Solution (100× in DMSO) | Alkaline phosphatases, Ser/Thr phosphatases, Acid and PP1 and PP2A |
C0008 |
SYBR Green qPCR Master Mix (Low ROX)
SYBR Green qPCR Master Mix (Low ROX) |
||
C0001 |
Protease Inhibitor Cocktail
蛋白酶抑制剂 Cocktail |
Solution (EDTA-Free,100× in DMSO) | Serine proteases, Aminopeptidases, Cysteine proteases, Aspartic proteases |
C0045 |
RIPA Lysis Buffer (Strong)
RIPA Lysis Buffer (Strong) |
||
C0006 |
SYBR Green qPCR Master Mix (No ROX)
SYBR Green qPCR Master Mix (No ROX) |
Cat. No. | Product Name | ||
---|---|---|---|
EC2000 | 全自动封板仪 | ||
Cat. No. | Product Name | ||
---|---|---|---|
EC4000 | TargetMol® 高通量开盖器 | ||
P-0.4-96U | Agen 96孔 0.4mL圆孔微孔板,U型底 | ||
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1819 | Kaempferol 3-neohesperidoside | PI3K; GSK-3; MEK | PI3K/Akt/mTOR signaling; MAPK; Stem Cells |
Kaempferol 3-neohesperidoside is a flavonoid. Kaempferol 3-neohesperidoside exhibits insulinomimetic effect on the rat soleus muscle. | |||
T124218 | Kaempferol 3-O-neohesperidoside 7-O-glucoside | ||